Satellite Symposium:
Current Challenges and Future Directions for the Treatment of Serious Microbial Infections in an Era of Increasing Drug Resistance (Not Official IDWeek Programming - Supported by an educational grant from Matinas BioPharma - See Affiliated Event Guide
Wednesday, October 7, 2015: 8:00 PM-10:00 PM
Room: 28--ABCDE

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the Official Program IDWeekTM 2015 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposium, Presentation Theater or Learning Lounge.


Edmund C. Tramont, MD, FACP (Chair)

Associate Director for Special Projects


Bethesda, Maryland


Peter G. Pappas, MD, FACP

William E. Dismukes Professor of Medicine

Principal Investigator, Mycoses Study Group

Division of Infectious Diseases

University of Alabama at Birmingham

Birmingham, Alabama


Barry Kreiswirth, PhD

Professor of Medicine

Director, PHRI TB Center

Public Health Research Institute

Rutgers, The State University of New Jersey

Newark, New Jersey


Parag Kumar, PharmD

Director, Clinical Pharmacokinetics Research Laboratory

Clinical Center Pharmacy Department

National Institutes of Health

Bethesda, Maryland


J Carl Craft, MD

Independent Infectious Diseases Consultant


Program Objectives:

At the conclusion of this program, attendees will be better able to:

  • DISCUSS the prevalence of toxicities and administrative challenges with currently available IV formulations of treatments for serious infections.
  • DESCRIBE the efficacy, tolerability, and adverse effects of current and emerging formulations of treatments for serious infections.
  • EVALAUTE patient care strategies that incorporate effective and appropriate treatment options for both bacterial and fungal infections.


Accreditation Statement—This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Rutgers, The State University of New Jersey and ASiM. Rutgers, The State University of New Jersey is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation Statement—Rutgers, The State University of New Jersey designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Agenda subject to change and was provided by:

ASiM; 166 W Main Street, Somerville, New Jersey, 08876.

This is a CME Certified Activity and was jointly provided by the Center for Continuing and Outreach Education at Rutgers Biomedical and Health Sciences and ASiM.

Please contact Adrienne Roser directly at (908) 253-9001, ext.  4 or for more information.

Target Audience: Infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.